Periostin promotes renal cyst growth and interstitial fibrosis in polycystic kidney disease

Kidney International

Volumn 85, Issue 4, 2014, Pages 845-854

  Wallace, Darren P ^a   White, Corey ^a   Savinkova, Lyudmyla ^a   Nivens, Emily ^a   Reif, Gail A ^a   Pinto, Cibele S ^a   Raman, Archana ^a   Parnell, Stephen C ^b   Conway, Simon J ^c   Fields, Timothy A ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ADPKD; Integrin linked kinase; Integrins; Osteoblast specific factor 2; Proliferation

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN S6; TRANSCRIPTION FACTOR RUNX2; CELL ADHESION MOLECULE; POSTN PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; KIDNEY CYST; KIDNEY MASS; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUBULE CELL; MALE; MOUSE; NEPHRONOPHTHISIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SURVIVAL TIME; WEIGHT REDUCTION; ANIMAL; FIBROSIS; KIDNEY; KNOCKOUT MOUSE; METABOLISM; ORGAN SIZE; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL ADHESION MOLECULES; CELL PROLIFERATION; FIBROSIS; KIDNEY; MALE; MICE, KNOCKOUT; ORGAN SIZE; POLYCYSTIC KIDNEY DISEASES; SIGNAL TRANSDUCTION;

EID: 84897954681     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.488     Document Type: Article

References (62)

1. Grantham JJ. 1992 Homer Smith Award. Fluid secretion, cellular proliferation, and the pathogenesis of renal epithelial cysts. J Am Soc Nephrol 1993; 3: 1841-1857.
2. Wilson PD, Hreniuk D, Gabow PA. Abnormal extracellular matrix and excessive growth of human adult polycystic kidney disease epithelia. J Cell Physiol 1992; 150: 360-369.
3. Mochizuki T, Wu G, Hayashi T et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996; 272: 1339-1342.
4. Harris PC. Molecular basis of polycystic kidney disease: PKD1, PKD2 and PKHD1. Curr Opin Nephrol Hypertens 2002; 11: 309-314.
5. Rossetti S, Strmecki L, Gamble V et al. Mutation analysis of the entire PKD1 gene: Genetic and diagnostic implications. Am J Hum Genet 2001; 68: 46-63.
6. Watnick T, Germino GG. Molecular basis of autosomal dominant polycystic kidney disease. Semin Nephrol 1999; 19: 327-343.
7. Qin S, Taglienti M, Nauli SM et al. Failure to ubiquitinate c-Met leads to hyperactivation of mTOR signaling in a mouse model of autosomal dominant polycystic kidney disease. J Clin Invest 2010; 120: 3617-3628.
8. Torres VE, Boletta A, Chapman A et al. Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases. Clin J Am Soc Nephrol 2010; 5: 1312-1329.
9. Weimbs T. Regulation of mTOR by polycystin-1: Is polycystic kidney disease a case of futile repair?. Cell Cycle 2006; 5: 2425-2429.
10. Wahl PR, Serra AL, Le Hir M et al. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD). Nephrol Dial Transplant 2006; 21: 598-604.
11. Wallace DP. Cyclic AMP-mediated cyst expansion. Biochim Biophys Acta 2011; 1812: 1291-1300.
12. Wallace DP, Quante MT, Reif GA et al. Periostin induces proliferation of human autosomal dominant polycystic kidney cells through alphaVintegrin receptor. Am J Physiol Renal Physiol 2008; 295: F1463-F1471.
13. Yamaguchi T, Hempson SJ, Reif GA et al. Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells. J Am Soc Nephrol 2006; 17: 178-187.
14. Yamaguchi T, Nagao S, Wallace DP et al. Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys. Kidney Int 2003; 63: 1983-1994.
15. Yamaguchi T, Wallace DP, Magenheimer BS et al. Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype. J Biol Chem 2004; 279: 40419-40430.
16. Belibi F, Ravichandran K, Zafar I et al. mTORC1/2 and rapamycin in female Han:SPRD rats with polycystic kidney disease. Am J Physiol Renal Physiol 2011; 300: F236-F244.
17. Song X, Di Giovanni V, He N et al. Systems biology of autosomal dominant polycystic kidney disease (ADPKD): Computational identification of gene expression pathways and integrated regulatory networks. Hum Mol Genet 2009; 18: 2328-2343.
18. Kudo A. Periostin in fibrillogenesis for tissue regeneration: Periostin actions inside and outside the cell. Cell Mol Life Sci 2011; 68: 3201-3207.
19. Takayama G, Arima K, Kanaji T et al. Periostin: A novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol 2006; 118: 98-104.
20. Norris RA, Damon B, Mironov V et al. Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem 2007; 101: 695-711.
21. Bao S, Ouyang G, Bai X et al. Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell 2004; 5: 329-339.
22. Gillan L, Matei D, Fishman DA et al. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res 2002; 62: 5358-5364.
23. Lindner V, Wang Q, Conley BA et al. Vascular injury induces expression of periostin: Implications for vascular cell differentiation and migration. Arterioscler Thromb Vasc Biol 2005; 25: 77-83.
24. Li G, Jin R, Norris RA et al. Periostin mediates vascular smooth muscle cell migration through the integrins alphavbeta3 and alphavbeta5 and focal adhesion kinase (FAK) pathway. Atherosclerosis 2010; 208: 358-365.
25. Shao R, Bao S, Bai X et al. Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol Cell Biol 2004; 24: 3992-4003.
26. Morra L, Rechsteiner M, Casagrande S et al. Relevance of periostin splice variants in renal cell carcinoma. Am J Pathol 2011; 179: 1513-1521.
27. Sorocos K, Kostoulias X, Cullen-McEwen L et al. Expression patterns and roles of periostin during kidney and ureter development. J Urol 2011; 186: 1537-1544.
28. Tai IT, Dai M, Chen LB. Periostin induction in tumor cell line explants and inhibition of in vitro cell growth by anti-periostin antibodies. Carcinogenesis 2005; 26: 908-915.
29. Kruzynska-Frejtag A, Machnicki M, Rogers R et al. Periostin (an osteoblastspecific factor) is expressed within the embryonic mouse heart during valve formation. Mech Dev 2001; 103: 183-188.
30. Stanton LW, Garrard LJ, Damm D et al. Altered patterns of gene expression in response to myocardial infarction. Circ Res 2000; 86: 939-945.
31. Norris RA, Kern CB, Wessels A et al. Identification and detection of the periostin gene in cardiac development. Anat Rec A Discov Mol Cell Evol Biol 2004; 281: 1227-1233.
32. Baril P, Gangeswaran R, Mahon PC et al. Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: Role of the beta4 integrin and the PI3k pathway. Oncogene 2007; 26: 2082-2094.
33. Riener MO, Fritzsche FR, Soll C et al. Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas. Histopathology 2010; 56: 600-606.
34. Sasaki H, Lo KM, Chen LB et al. Expression of Periostin, homologous with an insect cell adhesion molecule, as a prognostic marker in non-small cell lung cancers. Jpn J Cancer Res 2001; 92: 869-873.
35. Tischler V, Fritzsche FR, Wild PJ et al. Periostin is up-regulated in high grade and high stage prostate cancer. BMC Cancer 2010; 10: 273.
36. Kudo Y, Ogawa I, Kitajima S et al. Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer. Cancer Res 2006; 66: 6928-6935.
37. Takahashi H, Calvet JP, Dittemore-Hoover D et al. A hereditary model of slowly progressive polycystic kidney disease in the mouse. J Am Soc Nephrol 1991; 1: 980-989.
38. Olbrich H, Fliegauf M, Hoefele J et al. Mutations in a novel gene, NPHP3, cause adolescent nephronophthisis, tapeto-retinal degeneration and hepatic fibrosis. Nat Genet 2003; 34: 455-459.
39. Wallace DP, Hou YP, Huang ZL et al. Tracking kidney volume in mice with polycystic kidney disease by magnetic resonance imaging. Kidney Int 2008; 73: 778-781.
40. Rios H, Koushik SV, Wang H et al. periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype. Mol Cell Biol 2005; 25: 11131-11144.
41. Gattone VH 2nd, Sinders RM, Hornberger TA et al. Late progression of renal pathology and cyst enlargement is reduced by rapamycin in a mouse model of nephronophthisis. Kidney Int 2009; 76: 178-182.
42. Shillingford JM, Murcia NS, Larson CH et al. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci U S A 2006; 103: 5466-5471.
43. Bonnet CS, Aldred M, von Ruhland C et al. Defects in cell polarity underlie TSC and ADPKD-Associated cystogenesis. Hum Mol Genet 2009; 18: 2166-2176.
44. Manning BD, Tee AR, Logsdon MN et al. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol Cell 2002; 10: 151-162.
45. Lorts A, Schwanekamp JA, Baudino TA et al. Deletion of periostin reduces muscular dystrophy and fibrosis in mice by modulating the transforming growth factor-beta pathway. Proc Natl Acad Sci USA 2012; 109: 10978-10983.
46. Sidhu SS, Yuan S, Innes AL et al. Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma. Proc Natl Acad Sci USA 2010; 107: 14170-14175.
47. Ito T, Suzuki A, Imai E et al. Tornado extraction: A method to enrich and purify RNA from the nephrogenic zone of the neonatal rat kidney. Kidney Int 2002; 62: 763-769.
48. Calvet JP. Molecular genetics of polycystic kidney disease. J Nephrol 1998; 11: 24-34.
49. Conway SJ, Molkentin JD. Periostin as a heterofunctional regulator of cardiac development and disease. Curr Genomics 2008; 9: 548-555.
50. Horiuchi K, Amizuka N, Takeshita S et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res 1999; 14: 1239-1249.
51. Oka T, Xu J, Kaiser RA et al. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res 2007; 101: 313-321.
52. Snider P, Hinton RB, Moreno-Rodriguez RA et al. Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart. Circ Res 2008; 102: 752-760.
53. Grantham JJ, Mulamalla S, Swenson-Fields KI. Why kidneys fail in autosomal dominant polycystic kidney disease. Nat Rev Nephrol 2011; 7: 556-566.
54. Satirapoj B, Wang Y, Chamberlin MP et al. Periostin: Novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells. Nephrol Dial Transplant 2012; 27: 2702-2711.
55. Sen K, Lindenmeyer MT, Gaspert A et al. Periostin is induced in glomerular injury and expressed de novo in interstitial renal fibrosis. Am J Pathol 2011; 179: 1756-1767.
56. Okada H, Ban S, Nagao S et al. Progressive renal fibrosis in murine polycystic kidney disease: An immunohistochemical observation. Kidney Int 2000; 58: 587-597.
57. Gattone VH 2nd, Chen NX, Sinders RM et al. Calcimimetic inhibits late-stage cyst growth in ADPKD. J Am Soc Nephrol 2009; 20: 1527-1532.
58. Omori S, Hida M, Fujita H et al. Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease. J Am Soc Nephrol 2006; 17: 1604-1614.
59. Montes GS, Junqueira LC. The use of the picrosirius-polarization method for the study of the biopathology of collagen. Mem Inst Oswaldo Cruz 1991; 86(Suppl 3): 1-11.
60. Zhang H, Sun L, Wang W et al. Quantitative analysis of fibrosis formation on the microcapsule surface with the use of picro-sirius red staining, polarized light microscopy, and digital image analysis. J Biomed Mater Res A 2006; 76: 120-125.
61. Nagao S, Nishii K, Yoshihara D et al. Calcium channel inhibition accelerates polycystic kidney disease progression in the Cy/+ rat. Kidney Int 2008; 73: 269-277.
62. Farris AB, Adams CD, Brousaides N et al. Morphometric and visual evaluation of fibrosis in renal biopsies. J Am Soc Nephrol 2011; 22: 176-186.